Trials / Completed
CompletedNCT01360060
Analgesia After Cesarean Section
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 503 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulphate | Magnesium sulphate was infused for the management of preeclampsia at perioperative period. |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2011-05-25
- Last updated
- 2011-05-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01360060. Inclusion in this directory is not an endorsement.